INTRODUCTION
In recent years, general outcome prediction models using logistic regression models have become the cornerstone of performance evaluation since they allow the estimation of outcome probabilities that can be later related to actual death rates as an indicator of the effectiveness of care. However, the application of a model to a different population can only be done once the model has been tested and validated on that population [1] . Variations in case mix not accounted for by the original models can have a significant impact on its performance. Alternatively, the model could have been improperly developed or validated.
In this process of external validation off a population that is independent from the original sample, two assessments are especially important: discrimination and calibration. The first assessment tests the model refinement or spread, looking at the capability of the model to distinguish between patients who died and patients who survived, using the area under the Receiver Operating Characteristic (ROC) curve [2] ; the second assessment evaluates the degree of correspondence between the estimated probabilities of mortality and the actual mortality in the target population and can be tested with calibration curves, overall observed/expected (O/E) mortality ratio, or, formally, with two chi-square statistics, the H and C tests proposed by Hosmer and Lemeshow [3, 4] . Together, these measurements have become standard practice in the last few years.
Another source of incorrectness can be the presence in the target population of subsets of observations in which the model does not perform well [5] . This phenomenon is obviously more important when the study includes highly specialised intensive care units (ICUs) with unique patient characteristics. Its application in general ICUs can also be dependent from the characteristics of the underlying population. The impact of these phenomena has not been well characterised. However, its effects can be evaluated by testing the performance of the model across relevant subgroups, based on patient baseline characteristics (case mix), in order to identify in which subgroups of patients the model perform well (uniformity of fit).
As part of an international prospective study (EURICUS-I), the new admission Mortality Probability Model (MPM II ) was not able to adequately describe the population [6, 7] . For 0 this reason, according to recent suggestions [8] [9] [10] we customised the model to better understand the reasons underlying this poor fit. Two different strategies were chosen: the customisation of the logit (first-level customisation), and the customisation of the variables (second-level customisation). The impact of these two different strategies was evaluated using formal goodness-of-fit analyses, both in the overall sample and across relevant subgroups.
MATERIALS AND METHODS

THE DATABASE
The study used the database of the Foundation for Research on Intensive Care in Europe (FRICE) concerning data collected during a concerted action of the Biomed 1 program of the Commission of the European Communities called EURICUS-I (BMH1-CT93-1340). This study addressed the effects of organisation and management on the effectiveness and efficiency of ICUs in Europe. A complete description of methods and results will be published elsewhere, including the data collection of medical and non-medical data in 89 ICUs of 12 European countries [7] .
In each country, ICUs were the selected from university and non-university hospitals of different sizes. In order to generate the largest possible variation of organisation and management variables, the ICUs were selected so that at least each country would participate with four to eight ICUs operating at different levels of care [11] . Since the selection of ICUs was not random, it does not represent the ICUs of the respective country where they were selected.
DATA FOR MPM II 0
Data were collected during a 4-month period (October 3, 1994 to January 31, 1995) in all participating ICUs. The exclusionary criteria was the same as described in the original description of the MPM II model [12] : patients < 18 years of age, patients considered 0 readmissions, patients requiring acute coronary care, burn patients and patients in the postoperative period after coronary artery by-pass surgery. Four ICUs did not collect complete data on MPM II and were excluded from the final analysis. 0 Each patient was described using a simple set of variables that included all variables from the original MPM II model [12] . Basic demographic characteristics, including age and type of 0 patient (medical and scheduled/unscheduled surgical), were also collected. Data also included the principal diagnostic category on admission to the ICU using a list of 78 mutually exclusive diagnoses [13] .
Patients were followed up to hospital discharge, and their survival status was registered. Patients still in the hospital or with unknown outcome (113 patients) on May 1, 1995 (three months after the end of data collection) were dropped from the study.
METHODS
In the evaluation of the performance of the model, two different approaches were chosen: discrimination and calibration. To assess discrimination, the ability of the model to discriminate between patients who live and patients who die, we used the area under the ROC curve, computed by a modification of the Wilcoxon statistics, as proposed by Hanley and McNeil [2] . Comparison of the areas under the ROC curves was done using the Z statistic with correction for the correlation introduced by studying the same sample [14] .
Calibration, the degree of correspondence between predicted and observed mortality, was assessed by calibration curves, by O/E mortality ratios, and by the two chi-square statistics proposed by Hosmer and Lemeshow [3, 4] : the H test (collapsing the table based on fixed values of the estimated probabilities) and the C test (collapsing the table based on deciles of the estimated probabilities), and comparing the observed versus expected number of patients in each of the 20 cells to determine whether the discrepancies were acceptably small.
The computation of the O/E mortality ratios was made by dividing the number of observed deaths by the number of expected deaths as predicted by the model. Confidence intervals for the O/E mortality ratio were computed using a parametric approach, as described by Hosmer and Lemeshow [15] .
To evaluate the uniformity of fit, the capability of the model to adjust between subgroups, we stratified patients using two different strategies: patient baseline characteristics included in the model which we should expect would be taken into account (age group and type of patient), and patient baseline characteristics not included in the model (location in the hospital before ICU admission and diagnostic category). The choice of these groups was based on the literature and on our previous research [16, 17] and was defined before the beginning of the analysis.
Before the development of new logistic equations, the database was spliced randomly at ICU level in two samples: development (n = 6931) and validation (n = 3466). The customisation of the models was done with two different approaches. In first-level customisation, a new logistic regression using the original logit of MPM II as an independent variable was 0 developed. In second-level customisation, the coefficients where customised so that a new logistic regression equation was modelled in order to relate the 15 original independent variables in the MPM II model to the observed hospital outcome (our dependent variable).
0
The success of customisation was tested with the evaluation of discrimination, calibration, observed/expected mortality ratio, and uniformity of fit of the new models using standard techniques as described above.
Data analyses and statistics were performed using the Statistical Package for Social Sciences (SPSS) version 6.0.1 for Windows. 
CALIBRATION
The calibration curves for the three models are presented in Figure 1 . These curves demonstrate that as the predicted risk of hospital mortality increased, the proportion of patients who died also increased. However, for original MPM II predicted risks > 30 %, the 0 observed mortality within each risk group lay significantly below the diagonal line or, in other words, the model overestimated mortality in "sicker" patients. This pattern was corrected by both types of customisation.
Hosmer-Lemeshow goodness-of-fit test H revealed an inadequate performance of the original model (Table 3) . Customisation (either first-or second-level) significantly improved the fit. Hosmer-Lemeshow goodness-of-fit test C unveiled a similar result ( Table 3 ). The chi-square statistics after the second level-customisation were lower than after the first-level customisation ( The application of the original model yielded an overall O/E mortality ratio with 95 % confidence intervals that did not encompass 1.0 (development sample 0.86, 95 % confidence interval 0.82 to 0.89; validation sample 0.89, 95 % confidence interval 0.84 to 0.94); this fact implies that the model overestimates global mortality. After customisation, this problem was corrected (Table 3) .
UNIFORMITY OF FIT
In evaluating uniformity of fit, we created mutually exclusive subgroups according to patient baseline characteristics included in the model (type of patient and age group) and patient baseline characteristics not included in the model (location in the hospital prior to ICU admission and diagnostic category). As shown in Tables 4 to 6 , customisation corrected most, although not all deviations resulting from the application of the original MPM II . In subgroups defined according to type of patient (emergency surgery, scheduled surgery, and medical), a trend of underestimation of expected mortality was apparent in scheduled surgery patients; However, this underestimation was not statistically significant, as shown by HosmerLemeshow tests H and C.
With respect to age group, the original model overestimated mortality in older patients (age > 50 years). This problem was corrected most of the time by customisation. Relevant underand over-prediction was still present in very few groups, but we were unable to identify a clear pattern.
Stratification by location before ICU admission disclosed a very consistent pattern, with the original model overestimating mortality in patients admitted from the operative theatre/recovery room, emergency room, other ICUs, and other hospitals, and underestimating mortality in patients admitted from the ward. Customisation was able to correct the first problem almost completely but could not correct the second problem, with the new models still underestimating mortality in patients admitted from the ward. This can be very important for medical ICUs, where the percentage of admissions from the ward is usually greater.
Stratification by diagnostic category also unveiled problems, with the models systematically overestimating mortality in non-operative, cardiovascular patients and underestimating mortality in non-operative respiratory and neurological conditions and in post-operative gastrointestinal; these problems remained after customisation. In post-operative respiratory diagnosis no clear pattern was apparent, but Hosmer-Lemeshow tests H and C demonstrated significant deviations, not corrected by customisation. : p < 0.001 a Table 6 . Impact of customisation strategies on the uniformity of fit: stratification by diagnostic category. Data is presented on the validation sample (3466 patients) on the four most frequent categories in non-operative patients and in post-operative patients.
Diagnostic
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DISCUSSION
The application of general outcome prediction models to an independent population can only be done with confidence once the models were tested and validated on that population [1] . Several examples exist in the literature showing that models developed and validated even in large multicentre populations failed later to accurately predicted mortality in other populations. Some examples are the application of Acute Physiology and Chronic Health Evaluation (APACHE) II in the United Kingdom [18, 19] and Japan [20] ; the APACHE III in Brazil [21] ; the new Simplified Acute Physiology Score II in Spain [22] , Italy [10] , and Portugal [23] ; and the MPM in the United Kingdom [24] and Spain [25] . Although large differences in sample size among the studies can introduce the problem of how to interpret statistical significant differences that are quantitatively small, on average the findings reported suggests that the models did not accurately fit the data.
Several explanations have been advanced for this lack of fit. First, the impact of problems/errors due to ways of application and rules/judgements adopted to define cases, outcomes, and independent variables needs to be explored and quantified [26, 27] . Second, variations in unmeasured case mix, ICU demographics, the presence of other factors (clinical and non-clinical) not measured by the present severity scores, or variations in the quality of care [9, 18, [28] [29] [30] [31] [32] [33] . Third, the baseline of existing scores can drift over time, thus causing the intercept (on the logit scale of probabilities) to be displaced. This effect was used by others [34] to stress the necessity of periodic evaluation and/or modifications to the models and can be specially important when the models do not take into account diagnostic information, as is the case of MPM II [35] . One complementary explanation could be that existing models 0 do not take into account clinical and non-clinical factors at ICU level that have an important impact on prognosis [7] . If the variation between ICUs is important, it will impair the stability of the equations used to compute predicted mortality and preclude the use of indirect standardisation in the evaluation of differences between ICUs. Finally, the models may erroneously consider the relation between performance and severity of illness as constant, although performance can vary within ICUs according to the degree of severity of the patients [36] . All these points need to be addressed in the future in order to develop and utilise correctly the models.
Customisation, the modification of the equations that transform a score, or directly the measured variables, to a probability of mortality, has been suggested as one of the possible approaches when there is evidence that a given model is not fully appropriate. Preliminary work in this area [8, 10] showed that slight modifications of the logistic equations would suffice, although it is too soon to assume that this finding is always the case. More recently, a very elegant computer simulation work based on retrospective data on MPM II [9] comparing different strategies of customisation concluded that customisation was easy to perform and that when the sample size permits, the customisation of the coefficients was more effective than the customisation of the logit. However, to the best of our knowledge, no published study compared both strategies in a real situation, beginning with a model that did not fit.
In this study we analysed the impact of two different customisation strategies, comparing its effects on discrimination, calibration, and uniformity of fit in a cohort of patients in whom MPM II did not accurately predicted mortality. Our findings suggest that, at least for MPM 0 II in this cohort, customisation was not able to solve all the problems detected, especially in 0 stratified analysis. Second-level customisation was more effective than first-level customisation in improving the calibration of the model, and should probably be chosen as the preferential strategy to improve the fit of the model in a well-sized sample.
Customisation had no significant effect on discrimination. This can be justified by the lack of new variables, more predictive in this context. The addition of new variables to an existing model has been done before [37, 38] and can be an appropriate approach in some cases. However, it can lead to very complex models, needs the collection of special data and is also more expensive and time-consuming. The best trade off between the burden of data collection and accuracy should be tailored case by case. It should be noted that the aim of first-level customisation, a mathematical translation of the original logit in order to get a different probability of mortality, is to improve the calibration of a model and not to improve discrimination. First-level customisation should therefore not be considered when the improvement of this parameter is considered important.
Our results also demonstrate the importance of evaluating the uniformity of fit. We should realise that when applying a model (such as MPM II in the present case) to evaluate 0 mortality, we are doing no more than comparing our population with a reference population where the model has been developed. If the predictions are not accurate in important subgroups, such as unscheduled surgery patients or patients admitted from the ward, we might find differences that are only due to different patient compositions. At present, these differences preclude the use of MPM II model (even after customisation) as a basis for 0 performance evaluation in our population. The extent to which this phenomenon is due to an intrinsic weakness of the MPM II model or can be generalised to other outcome prediction 0 models should be empirically tested.
